Lantheus Holdings Enters Merger Agreement with Curium
Lantheus Holdings merges with Curium at $102.50 plus CVR
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
10 results loaded, newest first. End of these results.
TECH Acquires Bio-Techne
Merck KGaA agrees to acquire Bio-Techne, strengthening its leadership position in life sciences markets
AbbVie Acquires Apogee
AbbVie acquires Apogee Therapeutics in a $10.9 billion cash deal, expanding its immunology pipeline
NEE Sells $3.75B Debentures
NextEra Energy sells $3.75 billion junior subordinated debentures
DFTX +65% on Phase 3 Results
DFTX shares rise 65% on positive topline results from Phase 3 Emerge Study of DT120
APGE +45% on Acquisition
AbbVie to acquire Apogee Therapeutics, sending APGE stock up 45% premarket
CRH Acquires Arcosa
CRH is acquiring Arcosa, a leading US provider of aggregates and critical infrastructure products, for $8.5 billion
ABBV Acquires APGE
AbbVie is acquiring Apogee for $135.11 per share in cash to expand its pipeline of clinical-stage candidates for inflammatory and immunological diseases
ABBV Acquires APGE
AbbVie is acquiring Apogee Therapeutics to deepen its immunology portfolio
ABBV to Acquire APGE
AbbVie is closing in on a nearly $11 billion deal to acquire biotech company Apogee Therapeutics